Insmed gets grant for treatment of gram-positive pulmonary bacterial infections
According to GlobalData’s company profile on Insmed, Peptide pharmacophores was a key innovation area identified from patents. Insmed's grant share as of February 2024 was 58%. Grant share is based on the ratio of number of grants to total number of …